Back to search

BIA-Brukerstyrt innovasjonsarena

BP-17 - A national centre for manufacturing excellence in biopharma

Alternative title: BP-17 - Et nasjonalt senter for fremragende biofarmasøytisk produksjon

Awarded: NOK 0.50 mill.

Across industries, a lack of facilities for product testing and small-scale manufacturing has been identified as a bottle-neck for the transformation of Norwegian economy into a less oil-dependent future. With the current manufacturing site in Elverum and the production equipment acquired from the Norwegian Institute of Public Health (NIPH) as starting points, this project objectives are to identify the common manufacturing needs across biotechnological sector and the potential for developing a more attractive and sustainable centre for biopharma manufacturing expertise in Norway.

In the feasibility stage of the process Curida wants to perform a process analysis of current manufacturing processes at the Elverum site and Norwegian Institute of Public Health (NIPH). The process analysis will look at pilot and larger scale synthesis, mixing, filling, quality control and packaging processes. Synergies in terms of technology, knowledge and capabilities will be identified. The findings in the process analysis will be matched with the production needs of the companies that have grown out of Norwegian medical research. An analysis of what they need in terms of test services, small-scale manufacturing and upscaling will form the basis for further work in the main project.

Funding scheme:

BIA-Brukerstyrt innovasjonsarena